✦ LIBER ✦

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

✍ Scribed by Ryotaro Nakamura; Joycelynne M. Palmer; Margaret R. O’Donnell; Tracey Stiller; Sandra H. Thomas; Joseph Chao; Joseph Alvarnas; Pablo M. Parker; Vinod Pullarkat; Rodrigo Maegawa; Anthony S. Stein; David S. Snyder; Ravi Bhatia; Karen Chang; Shirong Wang; Ji-Lian Cai; David Senitzer; Stephen J. Forman

Book ID: 119318139
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 272 KB
Volume: 36
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2012.04.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved Outcome After Reduced Intensity

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (RI-HCT) For MDS Using Tacrolimus/Sirolimus As GVHD Prophylaxis

✍ R. Nakamura; J. Palmer; J. Chao; T. Stiller; V. Pullarkat; P. Parker; A. Stein; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Thrombotic Microangiopathy With Tacrolim

Thrombotic Microangiopathy With Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant

✍ S. Shayani; J. Palmer; T. Stiller; R. Rodriguez; T. Khuu; P.M. Parker; D.S. Snyd 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A phase II pilot study of tacrolimus/sir

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

✍ Rodriguez, R.; Nakamura, R.; Palmer, J. M.; Parker, P.; Shayani, S.; Nademanee, 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 260 KB

Allogeneic hematopoietic stem-cell trans

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Yeshurun, M; Yerushalmi, R; Avigdor, A; Ben- 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Response: A phase II pilot study of tacr

Response: A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 different conditioning regimens

✍ Nakamura, R.; Rodriguez, R.; Shayani, S.; Parker, P.; Forman, S. J. 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 147 KB

Allogeneic hematopoietic stem-cell trans

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Yerushalmi, R; Nagler, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB